Search clinical trials for: ZD1839
Total 70 results
-
AstraZenecaApproved for marketingNon Small Cell Lung Cancer (NSCLC)Taiwan, Thailand, Turkey, Brazil, Philippines, Russian Federation, Romania, Austria, Hungary, Bulgaria, Latvia, India, Argentina, Australia, Estonia, Malaysia, Mexico, Singapore, South Africa
-
Weill Medical College of Cornell UniversityTerminatedHead and Neck CancerUnited States
-
Dartmouth-Hitchcock Medical CenterM.D. Anderson Cancer Center; Dana-Farber Cancer Institute; AstraZeneca; Kentuckiana...CompletedNonresectable Adrenocortical CarcinomaUnited States
-
University of ZurichCompletedRecurrent GlioblastomaSwitzerland
-
Sidney Kimmel Cancer Center at Thomas Jefferson...AstraZenecaCompletedNon-Small Cell Lung Carcinoma (NSCLC)United States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)Terminated
-
National Cancer Institute (NCI)TerminatedRecurrent Head and Neck Cancer | Metastatic Head and Neck CancerUnited States
-
AstraZenecaCompletedCarcinoma | Neoplasm | Non-small-cell Lung | MetastasesUnited States
-
Stanford UniversityAstraZeneca; American Society of Clinical OncologyCompletedHead and Neck Cancer | Carcinoma, Squamous CellUnited States
-
University of ChicagoCompletedHead and Neck CancerUnited States
-
AstraZenecaCompletedHead and Neck CancerSpain
-
AstraZenecaCompletedNon-Metastatic Prostate CancerFinland
-
AstraZenecaCompletedNon Small Cell Lung CarcinomaAustralia
-
AstraZenecaCompleted
-
AstraZenecaCompletedNon-small-cell Lung CancerUnited Kingdom
-
AstraZenecaCompletedBreast CancerUnited States, Mexico, Venezuela, Colombia
-
Stanford UniversityAstraZeneca; Ligand PharmaceuticalsCompleted
-
AstraZenecaCompleted
-
Dartmouth-Hitchcock Medical CenterNational Cancer Institute (NCI); Norris Cotton Cancer CenterCompletedBreast CancerUnited States
-
California Cancer ConsortiumNational Cancer Institute (NCI)TerminatedKidney CancerUnited States